"We're sort of rewarding different values that I'm not sure I agree with," she says. "I categorically disagree with shooting unarmed men, you know, the police should never shoot an unarmed black man." She's trying to figure out who is capitulating to this culture and how to stop it.
Oncologist and epidemiologist Vinay Prasad argues that too many very expensive drugs get approved by the FDA that have very limited impact on the lives of patients. Prasad explains the incentives that distort the current system. The general problem, he explains to EconTalk host Russ Roberts, is the death of duty--too many players in the health care landscape and elsewhere stay quiet or do the wrong thing in order to serve themselves.